CCR4 ANTAGONISTS
Details for Australian Patent Application No. 2002310084 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/293,781 23.05.01 US
8 May 2003 Application Open to Public Inspection
Published as AU-A-2002310084
11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002310085-Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route
2002310083-SHROUDED CONNECTOR WITH IMPROVED TERMINAL PIN CONSTRUCTION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser